Trials / Unknown
UnknownNCT02815553
Cardiac Tumors Interventional (Radio Frequency/Laser Ablation)Therapy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
Currently, surgical removal remains the main clinical treatment for cardiac tumor patients. However, part of tumors are hard to completely resect. Also, as thoracoscopic surgeries induce great operation trauma, some patients cannot tolerate or do not will to take the operation. Therefore, new methods and techniques are in urgent need. Our center have a 12-year experience of intervention treatment for solid tumors and has conducted several animal experiments to verify the effectiveness of transthoracic puncture ablation and radiofrequency ablation for ventricular muscle. The purpose of this study is to conduct new method of direct transthoracic cardiac tumor-targeted Radiofrequency Ablation (RFA) or Laser induced Interstitial Thermotherapy (LITT), make minimally invasive treatment plans for cardiac tumor patients, and verify the safety and validity of intervention treatment in long term.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Direct Transthoracic Cardiac Tumor Radio Frequency Ablation Therapy | |
| PROCEDURE | Direct Transthoracic Cardiac Tumor Laser Ablation Therapy |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2022-08-01
- Completion
- 2022-08-01
- First posted
- 2016-06-28
- Last updated
- 2022-08-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02815553. Inclusion in this directory is not an endorsement.